论文信息 - PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis. - 字舞流文

PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.

G. D'Haens | W. Sandborn | B. Feagan | S. Danese | L. Mattheakis | B. Bressler | Suneel K. Gupta | R. Shames | R. Bhandari | D. Pugatch | N. Modi | R. Pai | Scott D. Lee | B. Kanwar | S. Schreiber | David Y Liu | S. Lee